In a significant development, the Federal Trade Commission (FTC), the Department of Justice’s Antitrust Division, and the U.S. Department of Health and Human Services (HHS) have launched a joint inquiry into the expanding control of private equity and corporate entities in healthcare. This inquiry aims to scrutinize healthcare transactions, both reportable and non-reportable, to evaluate their impact on patient care, worker safety, and healthcare affordability.

NATSAP, the National Association of Therapeutic Schools and Programs, acknowledges the importance of this inquiry and its potential implications for the healthcare landscape. As NATSAP members, who are deeply committed to ethical therapeutic interventions, it's essential to monitor such efforts closely. This inquiry could shape future regulatory policies and industry standards, directly affecting the operational landscape for therapeutic schools and programs.

NATSAP encourages its members to stay informed about this inquiry and its progress. While the inquiry unfolds, NATSAP remains vigilant, monitoring developments and assessing their potential impact on patient welfare and ethical healthcare practices. As dedicated professionals in the field of therapeutic intervention and support services, our collective engagement ensures that patient welfare remains a top priority in healthcare decision-making processes.